01 · The Goal

Build joints that resists disease and aging for a lifespan

The goal is joints that resists disease and aging for a whole lifetime — building joints that resist wear, inflammation, and aging across a whole lifespan. Behind the biology is a human being who would feel the difference in their daily life — that is the whole point.

02 · Why It Matters

Cartilage cushions every joint and barely heals on its own — once it wears away, the result is osteoarthritis, pain, and lost mobility for hundreds of millions. Repairing cartilage early, restoring joint movement, and keeping joints resilient for life would spare a vast share of the world’s disability and joint-replacement surgery. For the hundreds of millions with worn joints, this is the difference between a life narrowed by pain and one lived in full motion.

03 · What We’re Trying to Achieve

We are building the capability to keep joints resilient for life: proven foundations, early detection of drift, and the emerging science of aging. It means joining what medicine can already do with what it is learning to do — never overstating the line between them.

04 · How It Works

How it works

Proven foundations Clinical

Established habits and care build resilience — the foundation.

Detecting drift early Demonstrated in research

Monitoring catches the gradual changes of aging before they become disease.

Slowing aging Frontier

Targeting the biology of aging itself is an active frontier.

Lifelong, personalized care Advancing — some clinical

Sustaining resilience across a lifetime — personalized, monitored, and clinician-guided — is where prevention and emerging aging science meet.

05 · Who’s Building It

Cited as evidence the capability is real — not as partners or endorsers.

Government & programs

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS, NIH) · NIH regenerative-medicine programs. These public programs fund the foundational research that shows the capability is real.

Universities & institutes

Academic orthopaedics, cartilage-regeneration, and joint-biology research centers. Academic laboratories carry that science from discovery toward the clinic.

Enabling science base

chondrocyte & cartilage-matrix biology · joint stem cells · cartilage tissue engineering · biomechanics. — the established disciplines this capability is built upon.

06 · Technologies

The technologies: cartilage cell and matrix therapies, tissue-engineered cartilage, joint-preserving early interventions, and the biomechanics and rehabilitation that keep joints moving.

07 · Breakthroughs

Foundations Clinical

Proven habits build resilience.

Early detection Demonstrated

Monitoring catches aging early.

Aging science Frontier

Slowing aging is early-stage.

Geroscience moving to trials Clinical trials

Therapies targeting the biology of aging are entering human trials — early, but the first step from frontier toward medicine.

08 · Remaining Challenges

The honest challenges: building resilience works but must be sustained for life, and slowing the biology of aging is frontier. Resilience depends on protection and repair maturing alongside it. Sustaining these gains across an entire lifetime — and truly slowing the biology of aging — is the hard part: powerful in early study, not yet routine medicine. We tag each piece so its real stage is always clear.

09 · Mature Capability

The future, fully built

Joints stays resilient for life — built up, monitored, and protected from aging — so disease becomes rare rather than expected. — and the honest staging on this page shows just how much of that future is already real, and how much is still being built.

Honest boundary: each item is tagged for where it stands — demonstrated, clinical, or frontier. The science is real, funded, and accelerating. AI supports human clinicians; it never replaces them.
10 · Evidence Vault

The proof, for this capability

Cited as evidence the capability is real, not as partners or endorsers.

Foundations

Proven habits build resilience. Stage: Clinical.

Early detection

Monitoring catches aging. Stage: Demonstrated.

Aging biology

Slowing aging is early-stage. Stage: Frontier.

Honest framing

Real organizations are cited as evidence the capability is real — not as partners or endorsers. Foundations are clinical; slowing aging is frontier.

Where it stands

Each line above is tagged for its stage — demonstrated, clinical, or frontier — so the page shows exactly how far the real science has come, and how far is left.

Help build this future

Every signature grows the movement to make joint resilience real — and free at the point of need.

Paid for by Michael Floyd for President.

Scroll to Top